Analysts Viewpoint
Goldman upgrades Twist Bioscience Corp (TWST) rating to a Buy
Twist Bioscience Corp’s recent filing unveils that its Chief Executive Officer Leproust Emily M. unloaded Company’s shares for reported $0.15
Menu
Twist Bioscience Corp’s recent filing unveils that its Chief Executive Officer Leproust Emily M. unloaded Company’s shares for reported $0.15
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Twist Bioscience Corp’s recent filing unveils that its Chief Executive Officer Leproust Emily M. unloaded Company’s shares for reported $0.15
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Twist Bioscience Corp revealed its President and COO Finn Patrick John unloaded Company’s shares for reported $65483.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Twist Bioscience Corp’s recently made public that its President and COO Finn Patrick John unloaded Company’s shares for reported $65483.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Twist Bioscience